TrUTh is a breakthrough delivery platform designed to transport therapeutic molecules directly and precisely into the brain. Instead of relying on traditional drug carriers, which often get trapped in the liver or trigger unwanted immune responses, TrUTh uses a natural, biocompatible system inspired by the body’s own biology. This allows it to deliver treatments exactly where they are needed, with exceptional safety and flexibility. What makes TrUTh truly unique is its ability to combine multiple therapies, such as small drugs and RNA molecules, into a single delivery vehicle, with precise control over their relative doses. By overcoming the key barriers that limit current drug delivery technologies, TrUTh has the potential to unlock entirely new treatment strategies, turning complex combination therapies into practical, targeted, and highly effective solutions for cancer and beyond.